-
Ferring appoints President of the Ferring Research Institute
-Ferring, a biopharmaceutical company with its headquarters in Lausanne, Switzerland announced today that Dr. John L. McGuire has been appointed as the President of the Ferring Research Institute…
0 -
Dr Eberhard Zinn, Ferring Board Member, dies at 66
-Ferring founding board member, Dr. Eberhard Zinn died last week; he was 66 years old…
-
Research by 2003 Nobel Laureate in Chemistry Fills in ‘Scientific Gaps’ Necessary for Ferring Researchers to Develop Incontinence Product Focusing on the Kidney
-Ferring is exploring the links between recent Nobel Prize winning…
-
Updates in Infertility Congress
-Infertility experts from around the world gather to review the newest breakthroughs including…
-
Additional data for MENOPUR* (HP-hMG)
-The new data was based on a sub-analysis of the landmark trial EISG (European-Israeli Study Group) which was designed to demonstrate non-inferiority of MENOPUR (HP-hMG) when compared with rFSH in nearly 700 IVF and ICSI patients…
-
Ferring Acquires DUPOMAR
-The acquisition reinforces Ferring’s commitment to Latin America and strengthens the company in the field of women’s health…
-
Ferring Acquires NORPROLAC
-Ferring announced today the closing of a deal with Novartis Pharma AG for the acquisition of the worldwide manufacturing, marketing and distribution rights of NORPROLAC (quinagolide)…
PRESS RELEASE 2004
PRESS RELEASE 2004